IL130071A0 - Use of equilenin as an antioxidant - Google Patents
Use of equilenin as an antioxidantInfo
- Publication number
- IL130071A0 IL130071A0 IL13007197A IL13007197A IL130071A0 IL 130071 A0 IL130071 A0 IL 130071A0 IL 13007197 A IL13007197 A IL 13007197A IL 13007197 A IL13007197 A IL 13007197A IL 130071 A0 IL130071 A0 IL 130071A0
- Authority
- IL
- Israel
- Prior art keywords
- equilenin
- antioxidant
- Prior art date
Links
- 239000003963 antioxidant agent Substances 0.000 title 1
- 230000003078 antioxidant effect Effects 0.000 title 1
- PDRGHUMCVRDZLQ-UHFFFAOYSA-N d-equilenin Natural products OC1=CC=C2C(CCC3(C4CCC3=O)C)=C4C=CC2=C1 PDRGHUMCVRDZLQ-UHFFFAOYSA-N 0.000 title 1
- PDRGHUMCVRDZLQ-WMZOPIPTSA-N equilenin Chemical compound OC1=CC=C2C(CC[C@]3([C@H]4CCC3=O)C)=C4C=CC2=C1 PDRGHUMCVRDZLQ-WMZOPIPTSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US76257996A | 1996-12-10 | 1996-12-10 | |
| PCT/US1997/022154 WO1998025626A1 (en) | 1996-12-10 | 1997-12-05 | Use of equilenin as an antioxidant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL130071A0 true IL130071A0 (en) | 2000-02-29 |
Family
ID=25065472
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13007197A IL130071A0 (en) | 1996-12-10 | 1997-12-05 | Use of equilenin as an antioxidant |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0944391A1 (pt) |
| JP (1) | JP2001506628A (pt) |
| KR (1) | KR20000069412A (pt) |
| CN (1) | CN1239892A (pt) |
| AR (1) | AR010344A1 (pt) |
| AU (1) | AU743586B2 (pt) |
| BR (1) | BR9714384A (pt) |
| CA (1) | CA2272087A1 (pt) |
| HU (1) | HUP0000569A3 (pt) |
| IL (1) | IL130071A0 (pt) |
| NZ (1) | NZ336343A (pt) |
| TW (1) | TW466115B (pt) |
| WO (1) | WO1998025626A1 (pt) |
| ZA (1) | ZA9711052B (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6271221B1 (en) * | 1996-12-10 | 2001-08-07 | American Home Products Corporation | Use of equilenin as an antioxidant |
| DE19915576A1 (de) | 1999-03-30 | 2000-10-05 | Jenapharm Gmbh | Equileninderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
| EP1461025B1 (en) * | 2001-12-10 | 2011-07-27 | Du, Yansheng, Dr. | Treatment of parkinson's disease with cape |
| CN108958639B (zh) | 2017-05-19 | 2021-07-06 | 华邦电子股份有限公司 | 快闪存储器存储装置 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4154820A (en) * | 1976-02-23 | 1979-05-15 | Akzona Incorporated | Compositions containing alkali metal sulfate salts of conjugated estrogens and antioxidants as stabilizers |
| US4937238A (en) * | 1986-03-04 | 1990-06-26 | The Board Of Regents Of The University Of Nebraska | Prevention of mammary carcinoma |
| EP0240717A3 (en) * | 1986-03-04 | 1990-05-16 | Board of Regents of the University of Nebraska | Prevention of mammary carcinoma |
| US5545635A (en) * | 1995-05-23 | 1996-08-13 | Eli Lilly And Company | Inhibiting bone loss with equilenin |
-
1997
- 1997-11-27 TW TW086117838A patent/TW466115B/zh not_active IP Right Cessation
- 1997-12-05 JP JP52680498A patent/JP2001506628A/ja not_active Ceased
- 1997-12-05 EP EP97950808A patent/EP0944391A1/en not_active Withdrawn
- 1997-12-05 CA CA002272087A patent/CA2272087A1/en not_active Abandoned
- 1997-12-05 WO PCT/US1997/022154 patent/WO1998025626A1/en not_active Ceased
- 1997-12-05 KR KR1019997005181A patent/KR20000069412A/ko not_active Ceased
- 1997-12-05 BR BR9714384-7A patent/BR9714384A/pt not_active IP Right Cessation
- 1997-12-05 CN CN97180448A patent/CN1239892A/zh active Pending
- 1997-12-05 AU AU53707/98A patent/AU743586B2/en not_active Ceased
- 1997-12-05 NZ NZ336343A patent/NZ336343A/xx unknown
- 1997-12-05 IL IL13007197A patent/IL130071A0/xx unknown
- 1997-12-05 HU HU0000569A patent/HUP0000569A3/hu unknown
- 1997-12-09 AR ARP970105778A patent/AR010344A1/es not_active Application Discontinuation
- 1997-12-09 ZA ZA9711052A patent/ZA9711052B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA9711052B (en) | 1999-06-09 |
| AR010344A1 (es) | 2000-06-07 |
| JP2001506628A (ja) | 2001-05-22 |
| AU5370798A (en) | 1998-07-03 |
| HUP0000569A2 (hu) | 2000-10-28 |
| CN1239892A (zh) | 1999-12-29 |
| TW466115B (en) | 2001-12-01 |
| EP0944391A1 (en) | 1999-09-29 |
| KR20000069412A (ko) | 2000-11-25 |
| AU743586B2 (en) | 2002-01-31 |
| BR9714384A (pt) | 2000-05-16 |
| CA2272087A1 (en) | 1998-06-18 |
| NZ336343A (en) | 2000-11-24 |
| WO1998025626A1 (en) | 1998-06-18 |
| HUP0000569A3 (en) | 2000-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL129423A0 (en) | Improved preparation for use as contrast agent | |
| GB9600426D0 (en) | Compositions | |
| PL332118A1 (en) | Remineralisable compositions | |
| IL128718A0 (en) | Naaldase compositions | |
| IL130330A0 (en) | Endo-ectoparasiticidal compositions | |
| EP0897264A4 (en) | NATURAL ANTIOXIDANT COMPOSITION | |
| GB9624540D0 (en) | Compositions | |
| GB9620504D0 (en) | Compositions | |
| GB9623562D0 (en) | Sachet-packaged compositions | |
| HRP970569B1 (en) | Fharmaceutical compositions | |
| IL130071A0 (en) | Use of equilenin as an antioxidant | |
| GB9615628D0 (en) | Formulation | |
| HUP9603329A3 (en) | Use of 8,9-dehydroestrone as an antioxidant | |
| GB2308812B (en) | Antiseptic compositions | |
| IL130070A0 (en) | Use of 17beta-dihydroequilenin as an antioxidant | |
| GB9620503D0 (en) | Compositions | |
| HK1021143A (en) | Use of equilenin as an antioxidant | |
| GB9611365D0 (en) | Compositions | |
| GB9600545D0 (en) | Compositions | |
| ZA9711053B (en) | Antioxidant Antioxidant | |
| HK1021322A (en) | USE OF 17β-DIHYDROEQUILENIN AS AN ANTIOXIDANT | |
| PL313849A1 (en) | Beta-aminoesters of o-hydrobenzylamides | |
| IL117729A0 (en) | Use of nebivolol as an anti-atherogenic agent | |
| EP0907318A4 (en) | ANTIOXIDING COMPOUND | |
| TW358610U (en) | Improvement of inter-com |